{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:10:55Z","timestamp":1791587455554,"version":"4.3.4"},"reference-count":118,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.repc.2025.02.007","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:44:39Z","timestamp":1748918679000},"page":"445-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Primary heart failure with preserved ejection fraction: The intertwined pathophysiology and treatment of some of the most relevant phenotypes"],"prefix":"10.1016","volume":"44","author":[{"given":"Ryohei","family":"Ono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz","family":"Menezes Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2025.02.007_bib0595","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib0600","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amjcard.2023.08.169","article-title":"Supra-normal left ventricular function","volume":"207","author":"Ono","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0605","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0610","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.amjcard.2018.07.012","article-title":"Primary and secondary diastolic dysfunction in heart failure with preserved ejection fraction","volume":"122","author":"Del Buono","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0615","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ejhf.2894","volume":"25","author":"Anker","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib0620","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcmg.2018.12.034","article-title":"Diastolic dysfunction and heart failure with preserved ejection fraction: understanding mechanisms by using noninvasive methods","volume":"13","author":"Obokata","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.repc.2025.02.007_bib0625","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/CIRCULATIONAHA.115.015884","article-title":"Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone","volume":"132","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib0630","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ejhf.754","article-title":"Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial","volume":"19","author":"DeVore","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib0635","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/ejhf.2947","article-title":"Global longitudinal strain predicts clinical outcomes in patients with heart failure with preserved ejection fraction","volume":"25","author":"Brann","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib0640","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ejhf.659","article-title":"Left ventricular deformation at rest predicts exercise-induced elevation in pulmonary artery wedge pressure in patients with unexplained dyspnoea","volume":"19","author":"Biering-Sorensen","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib0645","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacc.2009.03.037","article-title":"The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion","volume":"54","author":"Tan","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0650","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ehjci\/jeu277","article-title":"Left ventricular global longitudinal strain is associated with exercise capacity in failing hearts with preserved and reduced ejection fraction","volume":"16","author":"Hasselberg","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.repc.2025.02.007_bib0655","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.02.007_bib0660","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2016.05.019","article-title":"The HFpEF obesity phenotype: the elephant in the room","volume":"68","author":"Kitzman","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0665","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005521","article-title":"Global longitudinal strain by echocardiography predicts long-term risk of cardiovascular morbidity and mortality in a low-risk general population: the Copenhagen City Heart Study","volume":"10","author":"Biering-Sorensen","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.repc.2025.02.007_bib0670","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1253\/circj.CJ-13-0214","article-title":"Left ventricular stiffening as therapeutic target for heart failure with preserved ejection fraction","volume":"77","author":"Sakata","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.repc.2025.02.007_bib0675","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00508-023-02195-3","article-title":"Hypertensive response to exercise, hypertension and heart failure with preserved ejection fraction (HFpEF)-a continuum of disease?","volume":"135","author":"Wiech","year":"2023","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.repc.2025.02.007_bib0680","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11886-009-0061-5","article-title":"Hypertension and diastolic heart failure","volume":"11","author":"Gradman","year":"2009","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.repc.2025.02.007_bib0685","doi-asserted-by":"crossref","first-page":"928232","DOI":"10.3389\/fphys.2022.928232","article-title":"Current understanding of molecular pathophysiology of heart failure with preserved ejection fraction","volume":"13","author":"Budde","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0690","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1291\/hypres.31.257","article-title":"Patients with a hypertensive response to exercise have impaired left ventricular diastolic function","volume":"31","author":"Takamura","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.repc.2025.02.007_bib0695","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ajh\/hps053","article-title":"Exercise-induced hypertension, cardiovascular events, and mortality in patients undergoing exercise stress testing: a systematic review and meta-analysis","volume":"26","author":"Schultz","year":"2013","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.repc.2025.02.007_bib0700","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","article-title":"Research priorities for heart failure with preserved ejection fraction: National Heart, Lung, and Blood Institute Working Group Summary","volume":"141","author":"Shah","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib0705","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jacc.2016.11.081","article-title":"Relationship between physical activity body mass index, and risk of heart failure","volume":"69","author":"Pandey","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0710","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.mayocp.2018.11.037","article-title":"Characterization of the obese phenotype of heart failure with preserved ejection fraction: a RELAX trial ancillary study","volume":"94","author":"Reddy","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.repc.2025.02.007_bib0715","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.apsb.2023.01.012","article-title":"Pathophysiology of obesity and its associated diseases","volume":"13","author":"Jin","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.repc.2025.02.007_bib0720","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2012.05.014","article-title":"Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction","volume":"110","author":"Anjan","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0725","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib0730","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12471-016-0810-1","article-title":"Understanding heart failure with preserved ejection fraction: where are we today?","volume":"24","author":"van Heerebeek","year":"2016","journal-title":"Neth Heart J"},{"key":"10.1016\/j.repc.2025.02.007_bib0735","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40256-024-00641-9","article-title":"Drug therapy for acute and chronic heart failure with preserved ejection fraction with hypertension: a state-of-the-art review","volume":"24","author":"Hiraiwa","year":"2024","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.repc.2025.02.007_bib0740","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/CIRCULATIONAHA.105.541078","article-title":"Age- and gender-related ventricular-vascular stiffening: a community-based study","volume":"112","author":"Redfield","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib0745","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/CIRCRESAHA.115.302929","article-title":"Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium","volume":"115","author":"Loffredo","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.repc.2025.02.007_bib0750","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ehjqcco\/qcw026","article-title":"Factors related to outcome in heart failure with a preserved (or normal) left ventricular ejection fraction","volume":"2","author":"Sanderson","year":"2016","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.repc.2025.02.007_bib0755","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.amjcard.2020.03.006","article-title":"Clinical demographic, and imaging correlates of anemia in heart failure with preserved ejection fraction (from the RELAX trial)","volume":"125","author":"Parcha","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0760","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0765","doi-asserted-by":"crossref","first-page":"e018574","DOI":"10.1161\/JAHA.120.018574","article-title":"Sex differences in heart failure with preserved ejection fraction","volume":"10","author":"Sotomi","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.repc.2025.02.007_bib0770","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.amjmed.2020.09.038","article-title":"Epidemiologic characterization of heart failure with reduced or preserved ejection fraction populations identified using medicare claims","volume":"134","author":"Desai","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.repc.2025.02.007_bib0775","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","article-title":"Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction","volume":"138","author":"Beale","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib0780","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1253\/circj.CJ-07-1028","article-title":"Gender-related difference in left ventricular diastolic elastance during exercise in patients with diabetes mellitus","volume":"72","author":"Ha","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.repc.2025.02.007_bib0785","doi-asserted-by":"crossref","first-page":"e001012","DOI":"10.1136\/openhrt-2019-001012","article-title":"Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"6","author":"Beale","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.repc.2025.02.007_bib0790","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for iron deficiency in patients with heart failure","volume":"79","author":"Masini","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0795","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.02.007_bib0800","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","article-title":"The burden of iron deficiency in heart failure: therapeutic approach","volume":"71","author":"Rocha","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0805","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11010125","article-title":"Iron deficiency in heart failure: mechanisms and pathophysiology","volume":"11","author":"Alnuwaysir","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.repc.2025.02.007_bib0810","doi-asserted-by":"crossref","first-page":"100705","DOI":"10.1016\/j.xkme.2023.100705","article-title":"Heart failure with preserved ejection fraction with CKD: a narrative review of a multispecialty disorder","volume":"5","author":"Patel","year":"2023","journal-title":"Kidney Med"},{"key":"10.1016\/j.repc.2025.02.007_bib0815","doi-asserted-by":"crossref","first-page":"757268","DOI":"10.3389\/fphys.2021.757268","article-title":"Iron deficiency impacts diastolic function aerobic exercise capacity, and patient phenotyping in heart failure with preserved ejection fraction: a subanalysis of the OptimEx-Clin study","volume":"12","author":"Gevaert","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0820","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamacardio.2021.1825","article-title":"Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"6","author":"Rush","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0825","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/CM9.0000000000002637","article-title":"Right ventricular-arterial uncoupling as an independent prognostic factor in acute heart failure with preserved ejection fraction accompanied with coronary artery disease","volume":"136","author":"Jia","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.repc.2025.02.007_bib0830","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/HCO.0000000000001082","article-title":"Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?","volume":"38","author":"Sinha","year":"2023","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0835","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.02.007_bib0840","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review","volume":"78","author":"Del Buono","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0845","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.cardfail.2023.08.027","article-title":"Heart failure investigator-reported sleep apnea and dapagliflozin: a patient-level pooled meta-analysis of DAPA-HF and DELIVER","volume":"30","author":"Butt","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib0850","doi-asserted-by":"crossref","first-page":"e028733","DOI":"10.1161\/JAHA.122.028733","article-title":"Positive airway pressure therapy adherence and health care resource use in patients with obstructive sleep apnea and heart failure with preserved ejection fraction","volume":"12","author":"Cistulli","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.repc.2025.02.007_bib0855","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jacc.2021.05.048","article-title":"Sleep disordered breathing and cardiovascular disease: JACC state-of-the-art review","volume":"78","author":"Cowie","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0860","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.CIR.0000061757.12581.15","article-title":"Sleep apnea and heart failure: Part I: obstructive sleep apnea","volume":"107","author":"Bradley","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib0865","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s00059-019-04850-w","article-title":"Left ventricular remodeling and dysfunction in obstructive sleep apnea: systematic review and meta-analysis","volume":"45","author":"Yu","year":"2020","journal-title":"Herz"},{"key":"10.1016\/j.repc.2025.02.007_bib0870","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/17476348.2.1.75","article-title":"Intermittent hypoxia: the culprit of oxidative stress, vascular inflammation and dyslipidemia in obstructive sleep apnea","volume":"2","author":"Lavie","year":"2008","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.repc.2025.02.007_bib0875","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2741\/e469","article-title":"Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea","volume":"4","author":"Lavie","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.repc.2025.02.007_bib0880","article-title":"Serum cytokines as biomarkers in heart failure with preserved ejection fraction and sleep apnea: a prospective cohort study","volume":"13","author":"Yakovlev","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.repc.2025.02.007_bib0885","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovic","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.02.007_bib0890","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.repc.2025.02.007_bib0895","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib0900","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/CIRCULATIONAHA.110.014506","article-title":"Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus","volume":"124","author":"Shenouda","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib0905","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib0910","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0915","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database","volume":"47","author":"Yancy","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0920","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.497","article-title":"Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation","volume":"18","author":"Ter Maaten","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib0925","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1152\/ajpendo.00264.2014","article-title":"FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability","volume":"307","author":"Silswal","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.repc.2025.02.007_bib0930","doi-asserted-by":"crossref","first-page":"c384","DOI":"10.1159\/000323664","article-title":"Hypovitaminosis D is associated with systemic inflammation and concentric myocardial geometric pattern in hemodialysis patients with low iPTH levels","volume":"118","author":"Bucharles","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.repc.2025.02.007_bib0935","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","article-title":"Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure","volume":"56","author":"Rostand","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.repc.2025.02.007_bib0940","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000351758","article-title":"Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease","volume":"38","author":"Moradi","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.repc.2025.02.007_bib0945","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.amjcard.2005.05.052","article-title":"Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension","volume":"96","author":"Tsioufis","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0950","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/CIRCULATIONAHA.110.940577","article-title":"Chronotropic incompetence: causes, consequences, and management","volume":"123","author":"Brubaker","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib0955","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction","volume":"114","author":"Borlaug","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib0960","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2023.0675","article-title":"Rate-adaptive atrial pacing for heart failure with preserved ejection fraction: the RAPID-HF randomized clinical trial","volume":"329","author":"Reddy","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2025.02.007_bib0965","doi-asserted-by":"crossref","first-page":"531","DOI":"10.31083\/j.rcm.2020.04.154","article-title":"Epidemiology and pathogenesis of heart failure with preserved ejection fraction","volume":"21","author":"Nair","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.repc.2025.02.007_bib0970","doi-asserted-by":"crossref","first-page":"e006331","DOI":"10.1161\/CIRCHEARTFAILURE.119.006331","article-title":"Mechanisms of chronotropic incompetence in heart failure with preserved ejection fraction","volume":"13","author":"Sarma","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib0975","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/eurjhf\/hfr161","article-title":"Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study","volume":"14","author":"Conraads","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib0980","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/ejhf.2146","article-title":"Determinants and consequences of heart rate and stroke volume response to exercise in patients with heart failure and preserved ejection fraction","volume":"23","author":"Wolsk","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib0985","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/jamacardio.2023.5500","article-title":"beta-Blocker withdrawal and functional capacity improvement in patients with heart failure with preserved ejection fraction","volume":"9","author":"Palau","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0990","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.jacc.2021.08.073","article-title":"Effect of beta-blocker withdrawal on functional capacity in heart failure and preserved ejection fraction","volume":"78","author":"Palau","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib0995","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/ejhf.876","article-title":"Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial","volume":"19","author":"Komajda","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib1000","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1161\/CIRCULATIONAHA.115.017119","article-title":"Effect of selective heart rate slowing in heart failure with preserved ejection fraction","volume":"132","author":"Pal","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib1005","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.02.007_bib1010","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib1015","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2025.02.007_bib1020","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2025.02.007_bib1025","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2025.02.007_bib1030","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2025.02.007_bib1035","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.02.007_bib1040","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin\u2013neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2025.02.007_bib1045","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/eurheartj\/ehad344","article-title":"Sacubitril\/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF","volume":"44","author":"Vaduganathan","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.02.007_bib1050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib1055","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2025.02.007_bib1060","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00392-024-02396-4","article-title":"Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment","volume":"113","author":"von Haehling","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.repc.2025.02.007_bib1065","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1016\/j.amjmed.2020.08.030","article-title":"Systolic blood pressure and outcomes in older patients with HFpEF and hypertension","volume":"134","author":"Faselis","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.repc.2025.02.007_bib1070","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.repc.2025.02.007_bib1075","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/archinternmed.2010.427","article-title":"Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk","volume":"171","author":"Sciarretta","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.repc.2025.02.007_bib1080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"315","author":"Kitzman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2025.02.007_bib1085","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jchf.2023.05.010","article-title":"Design and baseline characteristics of STEP-HFpEF program evaluating semaglutide in patients with obesity HFpEF phenotype","volume":"11","author":"Kosiborod","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib1090","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2025.02.007_bib1095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2025.02.007_bib1100","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/eurheartj\/ehac071","article-title":"Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis","volume":"43","author":"van Veldhuisen","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.02.007_bib1105","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.119.044491","article-title":"Effects of sacubitril\u2013valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF","volume":"141","author":"McMurray","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2025.02.007_bib1110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCHEARTFAILURE.112.970061","article-title":"Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial","volume":"5","author":"Lam","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib1115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jchf.2019.01.003","article-title":"Sex differences in outcomes and responses to spironolactone in heart failure with preserved ejection fraction: a secondary analysis of TOPCAT trial","volume":"7","author":"Merrill","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib1120","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10741-022-10275-1","article-title":"Sex-specific differences in the efficacy of heart failure therapies: a meta-analysis of 84,818 patients","volume":"28","author":"Wang","year":"2023","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.repc.2025.02.007_bib1125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ehf2.13753","article-title":"Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction","volume":"9","author":"Lopez-Vilella","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib1130","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jchf.2024.04.025","article-title":"Where are we with treatment and prevention of heart failure in patients post-myocardial infarction?","volume":"12","author":"Carberry","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib1135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2025.02.007_bib1140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ehf2.14857","article-title":"2024 update in heart failure","volume":"12","author":"Beghini","year":"2025","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib1145","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2025.02.007_bib1150","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","author":"Nuffield Department of Population Health Renal Studies Group","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2025.02.007_bib1155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2025.02.007_bib1160","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/thoraxjnl-2021-217205","article-title":"Adaptive servo ventilation for sleep apnoea in heart failure: the FACE study 3-month data","volume":"77","author":"Tamisier","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.repc.2025.02.007_bib1165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.sleep.2023.07.014","article-title":"FACE study: 2-year follow-up of adaptive servo-ventilation for sleep-disordered breathing in a chronic heart failure cohort","volume":"113","author":"Tamisier","year":"2024","journal-title":"Sleep Med"},{"key":"10.1016\/j.repc.2025.02.007_bib1170","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurjhf\/hfs197","article-title":"Impact of adaptive servo-ventilation on cardiovascular function and prognosis in heart failure patients with preserved left ventricular ejection fraction and sleep-disordered breathing","volume":"15","author":"Yoshihisa","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2025.02.007_bib1175","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01945-2019","article-title":"Obstructive sleep apnoea treatment and blood pressure: which phenotypes predict a response? A systematic review and meta-analysis","volume":"55","author":"Pengo","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.repc.2025.02.007_bib1180","doi-asserted-by":"crossref","first-page":"108356","DOI":"10.1016\/j.pharmthera.2023.108356","article-title":"The controversial role of beta-blockers in heart failure with preserved ejection fraction","volume":"243","author":"Wernhart","year":"2023","journal-title":"Pharmacol Ther"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255125001581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255125001581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T08:53:42Z","timestamp":1758185622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255125001581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":118,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0870255125001581"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2025.02.007","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary heart failure with preserved ejection fraction: The intertwined pathophysiology and treatment of some of the most relevant phenotypes","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2025.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}